UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of clinical oncology, ISSN 0732-183X, 05/2011, Volume 29, Issue 15_suppl, pp. 516 - 516
Journal Article
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1101 - 1108
Hematology, Oncology and Palliative Medicine | South America | Triazoles - administration & dosage | Breast Neoplasms - secondary | Humans | North America | Tamoxifen - administration & dosage | Nitriles - administration & dosage | Receptors, Steroid - analysis | Breast Neoplasms - chemistry | Neoplasms, Second Primary | Time Factors | Postmenopause | Female | Aromatase Inhibitors - administration & dosage | Double-Blind Method | Biomarkers, Tumor - analysis | Europe | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Selective Estrogen Receptor Modulators - administration & dosage | Treatment Outcome | Breast Neoplasms - drug therapy | Cross-Over Studies | New Zealand | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | South Africa | Australia | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2009, Volume 361, Issue 8, pp. 766 - 776
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | General aspects | Medical sciences | Tumors | Aromatase Inhibitors - administration & dosage | Triazoles - administration & dosage | Triazoles - adverse effects | Double-Blind Method | Drug Administration Schedule | Follow-Up Studies | Neoplasm Recurrence, Local - prevention & control | Antineoplastic Agents, Hormonal - administration & dosage | Humans | Kaplan-Meier Estimate | Proportional Hazards Models | Fractures, Bone - epidemiology | Breast Neoplasms - drug therapy | Tamoxifen - administration & dosage | Incidence | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Disease-Free Survival | Aromatase Inhibitors - adverse effects | Postmenopause | Female | Chemotherapy, Adjuvant | Tamoxifen - adverse effects | Nitriles - adverse effects | Women | Care and treatment | Usage | Breast cancer | Tamoxifen | Comparative analysis | Health aspects | Drug therapy | Womens health | Cancer therapies | Index Medicus | Abridged Index Medicus | Hormonal | Breast Neoplasms | epidemiology | administration & dosage | Triazoles | Nitriles | Adjuvant | drug therapy | Antineoplastic Agents | Local | prevention & control | Aromatase Inhibitors | Chemotherapy | Fractures | adverse effects | Bone | Neoplasm Recurrence | Cancer and Oncology | Kaplan-Meiers Estimate | Cancer och onkologi
Journal Article
Biogeosciences, ISSN 1726-4170, 2011, Volume 8, Issue 9, pp. 2785 - 2804
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2005, Volume 23, Issue 16_suppl, pp. 511 - 511
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2019, Volume 393, Issue 10191, pp. 2591 - 2598
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antimitotic agents | Breast cancer | Product development | Antineoplastic agents | Analysis | Heart | Adenocarcinoma | Statistical analysis | Angina pectoris | Cancer therapies | Survival | ErbB-2 protein | Patients | Evidence-based medicine | Nodes | Subgroups | Metastases | Data dictionaries | Ethics | Chemotherapy | Randomization | Consent | Safety | Ventricle | Trastuzumab | Tumors
Journal Article
The lancet oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 27 - 39
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Risk Factors | Neoplasm Recurrence, Local | Treatment Outcome | Antineoplastic Agents - administration & dosage | Breast Neoplasms - drug therapy | Disease Progression | Randomized Controlled Trials as Topic | Neoadjuvant Therapy - mortality | Neoplasm Metastasis | Time Factors | Antineoplastic Agents - adverse effects | Breast Neoplasms - pathology | Mastectomy, Segmental | Neoadjuvant Therapy - adverse effects | Adult | Breast Neoplasms - mortality | Female | Chemotherapy, Adjuvant | Neoplasm Staging | Lumpectomy | Medical research | Anthracyclines | Patient outcomes | Mortality | Analysis | Adjuvant treatment | Medicine, Experimental | Breast cancer | Rankings | Cancer | Index Medicus | Medicin och hälsovetenskap
Journal Article
Cellular physiology and biochemistry, ISSN 1015-8987, 07/2018, Volume 47, Issue 4, pp. 1509 - 1532
Original Paper | Heterotrimeric G-proteins | GNAI3 | Stereocilia bundle | Deafness gene | Cochlear hair cell maturation | Neural gain | GTP-Binding Protein alpha Subunits, Gi-Go - genetics | GTP-Binding Protein alpha Subunit, Gi2 - metabolism | Mice, Transgenic | Forkhead Transcription Factors - genetics | Hair Cells, Auditory, Inner - cytology | Nerve Tissue Proteins - genetics | Nerve Tissue Proteins - metabolism | Carrier Proteins - genetics | Animals | Carrier Proteins - metabolism | GTP-Binding Protein alpha Subunit, Gi2 - genetics | Forkhead Transcription Factors - metabolism | Hair Cells, Auditory, Inner - metabolism | Hearing - physiology | Mice | GTP-Binding Protein alpha Subunits, Gi-Go - metabolism | Proteins | Neurosciences | Cloning | Cell division | Physiology | Thyroid gland | Hearing impairment | Index Medicus | Gαi3/GNAI3
Journal Article
Oncologie (Paris, France), ISSN 1292-3818, 03/2004, Volume 6, Issue 2, pp. 114 - 119
Journal Article
Annals of oncology, ISSN 0923-7534, 04/2010, Volume 21, Issue 4, pp. 675 - 679
Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma - drug therapy | Breast Neoplasms - surgery | Carcinoma - surgery | Humans | Carcinoma - mortality | Treatment Outcome | Combined Modality Therapy | Breast Neoplasms - drug therapy | Disease Progression | Randomized Controlled Trials as Topic | Neoplasm, Residual | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Survival Analysis | Breast Neoplasms - mortality | Female | Carcinoma - pathology | Drug Resistance, Neoplasm - physiology | Index Medicus
Journal Article
British journal of cancer, ISSN 0007-0920, 11/2011, Volume 105, Issue 10, pp. 1480 - 1486
early breast cancer | dose-dense regimen | adjuvant treatment | docetaxel | skin toxicity | taxanes | Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Breast Neoplasms - drug therapy | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Adult | Female | Aged | Chemotherapy, Adjuvant | Epirubicin - adverse effects | Index Medicus | Clinical Study
Journal Article